ALPHA TEKNOVA, INC. Payments for Repurchase of Initial Public Offering
ALPHA TEKNOVA, INC. (TKNO) reported Payments for Repurchase of Initial Public Offering of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfInitialPublicOffering · last filed 2023-03-30
- ALPHA TEKNOVA, INC. payments for repurchase of initial public offering for the quarter ending 2022-12-31 was $0.00.
- ALPHA TEKNOVA, INC. payments for repurchase of initial public offering for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- ALPHA TEKNOVA, INC. payments for repurchase of initial public offering for the quarter ending 2021-12-31 was $0.00.
- ALPHA TEKNOVA, INC. payments for repurchase of initial public offering for the quarter ending 2021-09-30 was $1.27M.
- ALPHA TEKNOVA, INC. payments for repurchase of initial public offering for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- ALPHA TEKNOVA, INC. payments for repurchase of initial public offering for fiscal 2021 was $3.62M.
- ALPHA TEKNOVA, INC. payments for repurchase of initial public offering for fiscal 2020 was $0.00.
| Period end | Payments for Repurchase of Initial Public Offering 3 month | Payments for Repurchase of Initial Public Offering 6 month | Payments for Repurchase of Initial Public Offering 9 month | Payments for Repurchase of Initial Public Offering 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 10-K · filed 2023-03-30 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.27M derived: sum of 2 quarters · filed 2023-03-30 | $2.16M derived: sum of 3 quarters · filed 2023-03-30 | $3.62M 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.16M derived: sum of 2 quarters · filed 2022-11-14 | $3.62M 10-Q · filed 2022-11-14 | $3.62M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $891.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $2.35M 10-Q · filed 2022-08-11 | $2.35M derived: sum of 3 quarters · filed 2022-08-11 | $2.35M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.46M 10-Q · filed 2022-05-12 | $1.46M derived: sum of 2 quarters · filed 2022-05-12 | $1.46M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $0.00 derived: sum of 2 quarters · filed 2022-03-18 | $0.00 10-K · filed 2022-03-18 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |